Re: Thomas Powles, Robert A. Huddart, Tony Elliott, et al. Phase III, Double-blind, Randomized Trial that Compared Maintenance Lapatinib versus Placebo after First-line Chemotherapy in Patients with Human Epidermal Growth Factor Receptor 1/2-positive Metastatic Bladder Cancer. J Clin Oncol 2017;35:48-55 Knowing HER2 Status is Not Enough: A Molecular Subtype Approach to Bladder Cancer is Also Needed

被引：0

作者：

Eriksson, Pontus ^{[1
]}

Sjodahl, Gottfrid ^{[2
]}

Liedberg, Fredrik ^{[2
]}

机构：

[1] Lund Univ, Lund Univ Hosp, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden

[2] Lund Univ, Skane Univ Hosp, Dept Translat Med, SE-20502 Malmo, Sweden

来源：

关键词：

EXPRESSION; HER2;

D O I：

10.1016/j.eururo.2017.05.027

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E135 / E136

页数：2

共 1 条